-
Something wrong with this record ?
Leoligin, the Major Lignan from Edelweiss (Leontopodium nivale subsp. alpinum), Promotes Cholesterol Efflux from THP-1 Macrophages
L. Wang, A. Ladurner, S. Latkolik, S. Schwaiger, T. Linder, J. Hošek, V. Palme, N. Schilcher, O. Polanský, EH. Heiss, H. Stangl, MD. Mihovilovic, H. Stuppner, VM. Dirsch, AG. Atanasov,
Language English Country United States
Document type Journal Article
- MeSH
- ATP-Binding Cassette Transporters metabolism MeSH
- Asteraceae chemistry MeSH
- Atherosclerosis MeSH
- Biological Transport MeSH
- Dactinomycin pharmacology MeSH
- Humans MeSH
- Lignans chemistry isolation & purification pharmacology MeSH
- Macrophages metabolism MeSH
- RNA, Messenger metabolism MeSH
- Molecular Structure MeSH
- Oxazines metabolism MeSH
- Polymerase Chain Reaction MeSH
- Orphan Nuclear Receptors metabolism MeSH
- Blotting, Western MeSH
- Xanthenes metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Leoligin is a natural lignan found in Edelweiss (Leontopodium nivale ssp. alpinum). The aim of this study was to examine its influence on cholesterol efflux and to address the underlying mechanism of action. Leoligin increases apo A1- as well as 1% human plasma-mediated cholesterol efflux in THP-1 macrophages without affecting cell viability as determined by resazurin conversion. Western blot analysis revealed that the protein levels of the cholesterol efflux transporters ABCA1 and ABCG1 were upregulated, whereas the SR-B1 protein level remained unchanged upon treatment with leoligin (10 μM, 24 h). Quantitative reverse transcription PCR further uncovered that leoligin also increased ABCA1 and ABCG1 mRNA levels without affecting the half-life of the two mRNAs in the presence of actinomycin D, a transcription inhibitor. Proteome analysis revealed the modulation of protein expression fingerprint in the presence of leoligin. Taken together, these results suggest that leoligin induces cholesterol efflux in THP-1-derived macrophages by upregulating ABCA1 and ABCG1 expression. This novel activity suggests leoligin as a promising candidate for further studies addressing a possible preventive or therapeutic application in the context of atherosclerosis.
Department of Pharmacognosy University of Vienna Vienna Austria
Institute of Applied Synthetic Chemistry Vienna University of Technology Vienna Austria
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023959
- 003
- CZ-PrNML
- 005
- 20170906112514.0
- 007
- ta
- 008
- 170720s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jnatprod.6b00227 $2 doi
- 035 __
- $a (PubMed)27220065
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Wang, Limei $u Department of Pharmacognosy, University of Vienna , Vienna, Austria.
- 245 10
- $a Leoligin, the Major Lignan from Edelweiss (Leontopodium nivale subsp. alpinum), Promotes Cholesterol Efflux from THP-1 Macrophages / $c L. Wang, A. Ladurner, S. Latkolik, S. Schwaiger, T. Linder, J. Hošek, V. Palme, N. Schilcher, O. Polanský, EH. Heiss, H. Stangl, MD. Mihovilovic, H. Stuppner, VM. Dirsch, AG. Atanasov,
- 520 9_
- $a Leoligin is a natural lignan found in Edelweiss (Leontopodium nivale ssp. alpinum). The aim of this study was to examine its influence on cholesterol efflux and to address the underlying mechanism of action. Leoligin increases apo A1- as well as 1% human plasma-mediated cholesterol efflux in THP-1 macrophages without affecting cell viability as determined by resazurin conversion. Western blot analysis revealed that the protein levels of the cholesterol efflux transporters ABCA1 and ABCG1 were upregulated, whereas the SR-B1 protein level remained unchanged upon treatment with leoligin (10 μM, 24 h). Quantitative reverse transcription PCR further uncovered that leoligin also increased ABCA1 and ABCG1 mRNA levels without affecting the half-life of the two mRNAs in the presence of actinomycin D, a transcription inhibitor. Proteome analysis revealed the modulation of protein expression fingerprint in the presence of leoligin. Taken together, these results suggest that leoligin induces cholesterol efflux in THP-1-derived macrophages by upregulating ABCA1 and ABCG1 expression. This novel activity suggests leoligin as a promising candidate for further studies addressing a possible preventive or therapeutic application in the context of atherosclerosis.
- 650 _2
- $a ABC transportéry $x metabolismus $7 D018528
- 650 _2
- $a Asteraceae $x chemie $7 D019659
- 650 _2
- $a ateroskleróza $7 D050197
- 650 _2
- $a biologický transport $7 D001692
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a daktinomycin $x farmakologie $7 D003609
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lignany $x chemie $x izolace a purifikace $x farmakologie $7 D017705
- 650 _2
- $a makrofágy $x metabolismus $7 D008264
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a sirotčí receptory $x metabolismus $7 D057093
- 650 _2
- $a oxaziny $x metabolismus $7 D010078
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a xantheny $x metabolismus $7 D014966
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ladurner, Angela $u Department of Pharmacognosy, University of Vienna , Vienna, Austria.
- 700 1_
- $a Latkolik, Simone $u Department of Pharmacognosy, University of Vienna , Vienna, Austria.
- 700 1_
- $a Schwaiger, Stefan $u Institute of Pharmacy/Pharmacognosy, Center for Molecular Biosciences, University of Innsbruck , Innsbruck, Austria.
- 700 1_
- $a Linder, Thomas $u Institute of Applied Synthetic Chemistry, Vienna University of Technology , Vienna, Austria.
- 700 1_
- $a Hošek, Jan $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno , Brno, Czech Republic.
- 700 1_
- $a Palme, Veronika $u Department of Pharmacognosy, University of Vienna , Vienna, Austria.
- 700 1_
- $a Schilcher, Nicole $u Department of Pharmacognosy, University of Vienna , Vienna, Austria.
- 700 1_
- $a Polanský, Ondřej $u Veterinary Research Institute , Brno, Czech Republic.
- 700 1_
- $a Heiss, Elke H $u Department of Pharmacognosy, University of Vienna , Vienna, Austria.
- 700 1_
- $a Stangl, Herbert $u Institute of Medical Chemistry, Center for Pathobiochemistry and Genetics, Medical University of Vienna , Vienna, Austria.
- 700 1_
- $a Mihovilovic, Marko D $u Institute of Applied Synthetic Chemistry, Vienna University of Technology , Vienna, Austria.
- 700 1_
- $a Stuppner, Hermann $u Institute of Pharmacy/Pharmacognosy, Center for Molecular Biosciences, University of Innsbruck , Innsbruck, Austria.
- 700 1_
- $a Dirsch, Verena M $u Department of Pharmacognosy, University of Vienna , Vienna, Austria.
- 700 1_
- $a Atanasov, Atanas G $u Department of Pharmacognosy, University of Vienna , Vienna, Austria. Institute of Genetics and Animal Breeding of the Polish Academy of Sciences , 05-552 Jastrzebiec, Poland. $7 gn_A_00009691
- 773 0_
- $w MED00010055 $t Journal of natural products $x 1520-6025 $g Roč. 79, č. 6 (2016), s. 1651-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27220065 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170906113113 $b ABA008
- 999 __
- $a ok $b bmc $g 1239640 $s 984872
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 79 $c 6 $d 1651-7 $e 20160524 $i 1520-6025 $m Journal of natural products $n J Nat Prod $x MED00010055
- LZP __
- $a Pubmed-20170720